ORAI2, the crucial biomarker identified in this study, is an essential factor in predicting the temporal AD and non-AD samples alongside AP1S1, SYT13, and APOBEC3F, 7,892,609, respectively. Here, AP1S1 is linked to Alzheimer disease.